Robotic-Assisted Spine Surgery System Market Size, Share, and Trends Analysis - Global - 2025-2031 - Includes: Capital Equipment Market, Disposables and Other Accessories, and 1 more
Description
Global Robotic-Assisted Spine Surgery System Market Report, 2025 Edition
Executive Summary
The global robotic-assisted spine surgery system market was valued at $730 million in 2024. The market is expected to grow at a 14 percent CAGR to exceed $1.8 billion by 2031.
This report covers robotic-assisted spine surgery capital equipment, disposables and other accessories, and service and maintenance revenue. It quantifies unit sales, average selling prices, market values, growth rates and company shares. It also analyzes the growth drivers and limiters shaping adoption, regulatory and reimbursement pressures, platform installation trends and procedural expansion. Historical data is included to 2022 with forecasts to 2032.
The scope reflects how hospitals and spine surgery programs evaluate robotic platforms based on workflow, accuracy, radiation exposure, cost of adoption and integration with spinal implants. As robotic technology continues to expand into minimally invasive procedures and multi-level applications, purchasing decisions increasingly rely on long-term service and disposable economics rather than capital cost alone.
Market Overview
Robotic-assisted spine surgery continues to shift from an early-adoption technology to a standard component of modern spine care in many regions. Hospitals and surgical programs are investing in robotic systems to improve procedural consistency, streamline minimally invasive workflows and enhance outcomes across degenerative, deformity and trauma cases.
The market benefits from rapid growth in platform installations as vendors introduce flexible financial models such as leasing, per-use fees and bundled implant agreements. These models lower capital barriers for hospitals and ambulatory surgery centers and expand access in regions that historically faced financial constraints.
As robotic platforms become more widely available, associated revenue from disposables and accessories increases steadily. Because most systems require procedure-specific instrumentation, sensors, drapes and trackers, recurring disposable revenue grows each year as the installed base increases. Service and maintenance contracts also contribute to long-term revenue, supporting upgrades, software releases and workflow improvements. Over time, these recurring sources represent a larger share of total market value than capital equipment sales.
Global adoption is supported by strong clinical interest in minimally invasive techniques that reduce tissue disruption and speed recovery. Robotic systems provide improved screw placement accuracy, stable tool trajectories and reduced fluoroscopy exposure for surgeons and patients. These advantages support the upward trend in installations across high-volume spine centers, academic hospitals and integrated delivery networks.
At the same time, regulatory requirements, training curve demands and competition from navigation-only systems continue to shape purchasing behavior. Market value rises through higher procedure volumes and increased disposable use, even if capital unit growth moderates in some saturated regions.
Market Drivers
Clinical Benefits
Robotic-assisted systems are closely linked to the rise of minimally invasive spine surgery. The current clinical norm involves a posterior approach, and robotic technology supports this by reducing disruption of musculature and improving workflow precision. Short-term studies show reduced complication rates in complex procedures and comparable times to traditional methods in simpler procedures.
Robotic systems also support predictable screw placement, which decreases the likelihood of revision surgeries and improves overall outcomes. The reduction in surgical variation makes robotic assistance attractive for surgeons performing multi-level procedures and deformity corrections. Faster recovery, shorter lengths of stay and reduced postoperative pain all contribute to the clinical and economic case for adoption.
Flexible Financial Arrangements
As more large medtech companies enter the robotic spine market, flexible financing programs are becoming standard. Some vendors offer leasing programs with fixed monthly fees, while others provide per-case charges that spread system costs across procedure volumes. Spine and orthopedic system manufacturers increasingly offer heavy discounts or free capital equipment in exchange for implant usage commitments.
These earnout models have been particularly influential in driving platform penetration among hospitals that prefer predictable costs. As platform installations grow, recurring revenue from per-procedure disposables and accessories becomes more significant, strengthening long-term market expansion.
Revenue from Alternate Sources
Robotic-assisted spine systems generate revenue far beyond the initial system sale. Disposable instruments, sterile drapes, trackers, registration devices and workflow tools provide recurring income that grows with procedure adoption. Service and maintenance contracts represent another major revenue source, as systems require scheduled maintenance, software updates and technical support.
With the installed base increasing across global markets, companies benefit from a rising share of total revenue coming from disposables and service contracts. This trend enhances market stability because recurring revenue is less volatile than capital equipment sales.
Market Limiters
Cost of Using Robotic Systems
Robotic systems cost more than non-robotic navigation platforms, and this remains the primary limiter for adoption. Hospitals face competition for budget dollars across surgical departments, and robotic purchase decisions often require multi-year planning. While flexible financial arrangements help reduce upfront barriers, cost remains a hurdle for lower-volume centers.
As larger companies enter the market, bundling of implants, navigation systems and service contracts will continue to shape pricing. In some cases, implant-driven strategies may limit the ability of robotics-focused companies to compete if they do not offer comparable implant portfolios.
Training Period
Robotic systems require dedicated training for both surgeons and operating room staff. Although vendors provide training programs, surgeons typically need multiple procedures to gain proficiency. In busy operating rooms, limited time for training may delay adoption. Some surgeons remain reluctant to shift from established manual or navigation-only workflows, particularly when current outcomes are already strong.
The training burden affects procedure volume as teams learn new workflows, and temporarily longer procedure times may reduce daily caseloads. These factors can slow the speed at which hospitals adopt robotic systems.
Regulation
Robotic-assisted surgical devices face stringent regulatory review from national authorities, including the U.S. FDA, European agencies and regulatory bodies in Asia-Pacific and Latin America. Approval timelines for new systems and expanded indications can be long. In several regions, regulatory and reimbursement requirements must be addressed simultaneously, extending the time to commercialization.
Because newer robotic systems often involve software, imaging integration and advanced safety controls, regulatory pathways may require additional clinical data before approval. These factors increase time and development costs and can slow market expansion.
Market Coverage and Data Scope
Quantitative coverage: market size, market shares, forecasts, growth rates, units sold and average selling prices.
Qualitative coverage: growth trends, limiters, competitive analysis, SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, regulatory considerations and disease overviews that shape demand for robotic-assisted spine systems.
Time frame: base year 2024, forecasts from 2025 to 2032, historical data from 2022 to 2024.
Data sources: primary interviews with industry leaders, regulatory filings, government procedure data, hospital procurement data, import and export databases and iData Research’s internal market models.
Method note: revenue is modeled from unit volumes multiplied by ASPs and validated against procedure volumes, installation rates and replacement cycles.
Care settings: hospitals, academic medical centers and select ambulatory surgery centers performing spine surgery.
Markets Covered and Segmentation
Robotic-Assisted Spine Surgery System Market
By revenue type:
Capital equipment
Disposables and other accessories
Service and maintenance revenue
Unit analysis applies to:
Capital platforms installed annually and procedure volumes that generate disposable consumption.
Competitive Analysis
Medtronic
Medtronic led the global robotic-assisted spine surgery system market in 2024. The company markets the MAZOR X Stealth Edition, a robotic platform integrated with navigation and intraoperative planning tools. Medtronic’s acquisition of Mazor Robotics in 2018 provided a foundation for the MAZOR X platform, which remains the most widely adopted robotic spine system. The company’s strong implant portfolio and established presence in spinal hardware allow it to bundle packages that combine implants, disposables and navigation tools, enhancing competitiveness.
Globus Medical
Globus Medical held the second-leading position globally. Its ExcelsiusGPS platform combines robotic guidance with navigation in a single unit designed for both orthopedic and neurosurgical spine procedures. The system is intended to support minimally invasive workflows and is compatible with Globus’s implants and instruments. As Globus expands internationally, ExcelsiusGPS installations continue to rise, supported by the company’s integrated portfolio and emphasis on workflow efficiency.
Brainlab
Brainlab held the third-leading position in 2024. The company offers the Cirq robotic platform, which is designed as a modular system that supports both spine and neurosurgery. Cirq is differentiated by its lower ASP compared with competitors, making it accessible to hospitals that face financial constraints. The system can be paired with Brainlab’s imaging and navigation tools, allowing facilities to build integrated technology ecosystems. Brainlab’s focus on affordability and workflow adaptability has helped drive widespread adoption in select regions.
Technology and Practice Trends
Robotic-assisted spine surgery continues to evolve as vendors refine accuracy, workflow integration and imaging compatibility. Several technological trends are shaping the market:
Artificial intelligence and automated planning tools enhance surgical preparation and support consistency in multi-level procedures.
Improved sensor technologies streamline registration workflows, reducing intraoperative steps.
Integration with intraoperative CT and 3D imaging platforms expands the range of procedures suitable for robotic assistance.
Disposable instrument kits designed specifically for robotic workflows increase procedural efficiency.
Hybrid systems that combine navigation, robotics and imaging continue to gain traction, as facilities prefer unified platforms rather than fragmented technology solutions.
As outpatient spine surgery grows, vendors are exploring smaller, mobile robotic units that support minimally invasive procedures in ambulatory settings.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
This report answers key questions, including:
Where is robotic-assisted spine surgery adoption accelerating most quickly and which segments drive future growth.
How financial models such as leasing, per-use fees and implant bundling will influence system placement and competitive positioning.
How hospitals evaluate robotic platforms relative to navigation-only systems and traditional methods.
Which clinical applications are growing fastest and how procedural expansion influences disposable revenues.
What risks to growth exist, including regulatory delays, cost pressures, training burdens and competition from navigation and MIS approaches.
How competitors differentiate through imaging integration, accuracy metrics, workflow efficiency and ecosystem design.
How vendors can strengthen value propositions to surgeons and health systems through clinical evidence, disposable optimization and service support.
The global robotic-assisted spine surgery system market report from iData Research provides a detailed and data-driven foundation that supports commercial planning, portfolio development, competitive benchmarking and long-term investment decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global robotic-assisted spine surgery system market was valued at $730 million in 2024. The market is expected to grow at a 14 percent CAGR to exceed $1.8 billion by 2031.
This report covers robotic-assisted spine surgery capital equipment, disposables and other accessories, and service and maintenance revenue. It quantifies unit sales, average selling prices, market values, growth rates and company shares. It also analyzes the growth drivers and limiters shaping adoption, regulatory and reimbursement pressures, platform installation trends and procedural expansion. Historical data is included to 2022 with forecasts to 2032.
The scope reflects how hospitals and spine surgery programs evaluate robotic platforms based on workflow, accuracy, radiation exposure, cost of adoption and integration with spinal implants. As robotic technology continues to expand into minimally invasive procedures and multi-level applications, purchasing decisions increasingly rely on long-term service and disposable economics rather than capital cost alone.
Market Overview
Robotic-assisted spine surgery continues to shift from an early-adoption technology to a standard component of modern spine care in many regions. Hospitals and surgical programs are investing in robotic systems to improve procedural consistency, streamline minimally invasive workflows and enhance outcomes across degenerative, deformity and trauma cases.
The market benefits from rapid growth in platform installations as vendors introduce flexible financial models such as leasing, per-use fees and bundled implant agreements. These models lower capital barriers for hospitals and ambulatory surgery centers and expand access in regions that historically faced financial constraints.
As robotic platforms become more widely available, associated revenue from disposables and accessories increases steadily. Because most systems require procedure-specific instrumentation, sensors, drapes and trackers, recurring disposable revenue grows each year as the installed base increases. Service and maintenance contracts also contribute to long-term revenue, supporting upgrades, software releases and workflow improvements. Over time, these recurring sources represent a larger share of total market value than capital equipment sales.
Global adoption is supported by strong clinical interest in minimally invasive techniques that reduce tissue disruption and speed recovery. Robotic systems provide improved screw placement accuracy, stable tool trajectories and reduced fluoroscopy exposure for surgeons and patients. These advantages support the upward trend in installations across high-volume spine centers, academic hospitals and integrated delivery networks.
At the same time, regulatory requirements, training curve demands and competition from navigation-only systems continue to shape purchasing behavior. Market value rises through higher procedure volumes and increased disposable use, even if capital unit growth moderates in some saturated regions.
Market Drivers
Clinical Benefits
Robotic-assisted systems are closely linked to the rise of minimally invasive spine surgery. The current clinical norm involves a posterior approach, and robotic technology supports this by reducing disruption of musculature and improving workflow precision. Short-term studies show reduced complication rates in complex procedures and comparable times to traditional methods in simpler procedures.
Robotic systems also support predictable screw placement, which decreases the likelihood of revision surgeries and improves overall outcomes. The reduction in surgical variation makes robotic assistance attractive for surgeons performing multi-level procedures and deformity corrections. Faster recovery, shorter lengths of stay and reduced postoperative pain all contribute to the clinical and economic case for adoption.
Flexible Financial Arrangements
As more large medtech companies enter the robotic spine market, flexible financing programs are becoming standard. Some vendors offer leasing programs with fixed monthly fees, while others provide per-case charges that spread system costs across procedure volumes. Spine and orthopedic system manufacturers increasingly offer heavy discounts or free capital equipment in exchange for implant usage commitments.
These earnout models have been particularly influential in driving platform penetration among hospitals that prefer predictable costs. As platform installations grow, recurring revenue from per-procedure disposables and accessories becomes more significant, strengthening long-term market expansion.
Revenue from Alternate Sources
Robotic-assisted spine systems generate revenue far beyond the initial system sale. Disposable instruments, sterile drapes, trackers, registration devices and workflow tools provide recurring income that grows with procedure adoption. Service and maintenance contracts represent another major revenue source, as systems require scheduled maintenance, software updates and technical support.
With the installed base increasing across global markets, companies benefit from a rising share of total revenue coming from disposables and service contracts. This trend enhances market stability because recurring revenue is less volatile than capital equipment sales.
Market Limiters
Cost of Using Robotic Systems
Robotic systems cost more than non-robotic navigation platforms, and this remains the primary limiter for adoption. Hospitals face competition for budget dollars across surgical departments, and robotic purchase decisions often require multi-year planning. While flexible financial arrangements help reduce upfront barriers, cost remains a hurdle for lower-volume centers.
As larger companies enter the market, bundling of implants, navigation systems and service contracts will continue to shape pricing. In some cases, implant-driven strategies may limit the ability of robotics-focused companies to compete if they do not offer comparable implant portfolios.
Training Period
Robotic systems require dedicated training for both surgeons and operating room staff. Although vendors provide training programs, surgeons typically need multiple procedures to gain proficiency. In busy operating rooms, limited time for training may delay adoption. Some surgeons remain reluctant to shift from established manual or navigation-only workflows, particularly when current outcomes are already strong.
The training burden affects procedure volume as teams learn new workflows, and temporarily longer procedure times may reduce daily caseloads. These factors can slow the speed at which hospitals adopt robotic systems.
Regulation
Robotic-assisted surgical devices face stringent regulatory review from national authorities, including the U.S. FDA, European agencies and regulatory bodies in Asia-Pacific and Latin America. Approval timelines for new systems and expanded indications can be long. In several regions, regulatory and reimbursement requirements must be addressed simultaneously, extending the time to commercialization.
Because newer robotic systems often involve software, imaging integration and advanced safety controls, regulatory pathways may require additional clinical data before approval. These factors increase time and development costs and can slow market expansion.
Market Coverage and Data Scope
Quantitative coverage: market size, market shares, forecasts, growth rates, units sold and average selling prices.
Qualitative coverage: growth trends, limiters, competitive analysis, SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, regulatory considerations and disease overviews that shape demand for robotic-assisted spine systems.
Time frame: base year 2024, forecasts from 2025 to 2032, historical data from 2022 to 2024.
Data sources: primary interviews with industry leaders, regulatory filings, government procedure data, hospital procurement data, import and export databases and iData Research’s internal market models.
Method note: revenue is modeled from unit volumes multiplied by ASPs and validated against procedure volumes, installation rates and replacement cycles.
Care settings: hospitals, academic medical centers and select ambulatory surgery centers performing spine surgery.
Markets Covered and Segmentation
Robotic-Assisted Spine Surgery System Market
By revenue type:
Capital equipment
Disposables and other accessories
Service and maintenance revenue
Unit analysis applies to:
Capital platforms installed annually and procedure volumes that generate disposable consumption.
Competitive Analysis
Medtronic
Medtronic led the global robotic-assisted spine surgery system market in 2024. The company markets the MAZOR X Stealth Edition, a robotic platform integrated with navigation and intraoperative planning tools. Medtronic’s acquisition of Mazor Robotics in 2018 provided a foundation for the MAZOR X platform, which remains the most widely adopted robotic spine system. The company’s strong implant portfolio and established presence in spinal hardware allow it to bundle packages that combine implants, disposables and navigation tools, enhancing competitiveness.
Globus Medical
Globus Medical held the second-leading position globally. Its ExcelsiusGPS platform combines robotic guidance with navigation in a single unit designed for both orthopedic and neurosurgical spine procedures. The system is intended to support minimally invasive workflows and is compatible with Globus’s implants and instruments. As Globus expands internationally, ExcelsiusGPS installations continue to rise, supported by the company’s integrated portfolio and emphasis on workflow efficiency.
Brainlab
Brainlab held the third-leading position in 2024. The company offers the Cirq robotic platform, which is designed as a modular system that supports both spine and neurosurgery. Cirq is differentiated by its lower ASP compared with competitors, making it accessible to hospitals that face financial constraints. The system can be paired with Brainlab’s imaging and navigation tools, allowing facilities to build integrated technology ecosystems. Brainlab’s focus on affordability and workflow adaptability has helped drive widespread adoption in select regions.
Technology and Practice Trends
Robotic-assisted spine surgery continues to evolve as vendors refine accuracy, workflow integration and imaging compatibility. Several technological trends are shaping the market:
Artificial intelligence and automated planning tools enhance surgical preparation and support consistency in multi-level procedures.
Improved sensor technologies streamline registration workflows, reducing intraoperative steps.
Integration with intraoperative CT and 3D imaging platforms expands the range of procedures suitable for robotic assistance.
Disposable instrument kits designed specifically for robotic workflows increase procedural efficiency.
Hybrid systems that combine navigation, robotics and imaging continue to gain traction, as facilities prefer unified platforms rather than fragmented technology solutions.
As outpatient spine surgery grows, vendors are exploring smaller, mobile robotic units that support minimally invasive procedures in ambulatory settings.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
This report answers key questions, including:
Where is robotic-assisted spine surgery adoption accelerating most quickly and which segments drive future growth.
How financial models such as leasing, per-use fees and implant bundling will influence system placement and competitive positioning.
How hospitals evaluate robotic platforms relative to navigation-only systems and traditional methods.
Which clinical applications are growing fastest and how procedural expansion influences disposable revenues.
What risks to growth exist, including regulatory delays, cost pressures, training burdens and competition from navigation and MIS approaches.
How competitors differentiate through imaging integration, accuracy metrics, workflow efficiency and ecosystem design.
How vendors can strengthen value propositions to surgeons and health systems through clinical evidence, disposable optimization and service support.
The global robotic-assisted spine surgery system market report from iData Research provides a detailed and data-driven foundation that supports commercial planning, portfolio development, competitive benchmarking and long-term investment decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
82 Pages
- Research Methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems And Perform Secondary Research
- Step 3: Preparation For Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast And Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review And Market Release
- Step 9: Customer Feedback And Market Monitoring
- Disease Overview
- 2.1 Medical Conditions
- 2.1.1 Cardiac Conditions
- 2.1.1.1 Coronary Artery Disease
- 2.1.1.2 Mitral Valve Prolapse
- 2.1.2 Colorectal Conditions
- 2.1.2.1 Colorectal Cancer
- 2.1.2.2 Diverticulitis
- 2.1.2.3 Inflammatory Bowel Disease
- 2.1.3 Digestive Tract Conditions
- 2.1.3.1 Achalasia
- 2.1.3.2 Gallbladder Attack
- 2.1.3.3 Gastroesophageal Reflux Disease
- 2.1.3.4 Hernia
- 2.1.3.5 Stomach Cancer
- 2.1.4 Ear, Nose And Throat (Ent) Conditions
- 2.1.4.1 Cholesteatomas
- 2.1.4.2 Chronic Sinusitis
- 2.1.4.3 Otitis Media
- 2.1.4.4 Otosclerosis
- 2.1.4.5 Tonsillitis
- 2.1.5 Gynecological Conditions
- 2.1.5.1 Endometriosis
- 2.1.5.2 Gynecological Cancers
- 2.1.5.3 Menorrhagia
- 2.1.5.4 Pelvic Prolapse
- 2.1.5.5 Uterine Fibroids
- 2.1.6 Neurosurgical Conditions
- 2.1.6.1 Brain Tumor
- 2.1.6.2 Communicating Hydrocephalus
- 2.1.6.3 Hydrocephalus
- 2.1.6.4 Intracranial Aneurysm
- 2.1.6.5 Intracranial Atherosclerosis Disease
- 2.1.6.6 Intracranial Pressure
- 2.1.6.7 Non-Communicating Hydrocephalus
- 2.1.6.8 Normal Pressure Hydrocephalus
- 2.1.7 Orthopedic Conditions
- 2.1.7.1 Arthritis
- 2.1.7.2 Fractures
- 2.1.7.3 Osteoporosis
- 2.1.8 Spinal Conditions
- 2.1.8.1 Herniated Disc
- 2.1.8.2 Kyphosis
- 2.1.8.3 Scoliosis
- 2.1.8.4 Spinal Stenosis
- 2.1.8.5 Spondylosis
- 2.1.9 Urological Conditions
- 2.1.9.1 Benign Prostatic Hyperplasia (Bph)
- 2.1.9.2 Bladder Cancer
- 2.1.9.3 Kidney Cancer
- 2.1.9.4 Prostate Cancer
- Robotic-Assisted Spine Surgery System Market
- 12.1 Executive Summary
- 12.1.1 Global Robotic-Assisted Spine Surgery System Market Overview
- 12.1.2 Competitive Analysis
- 12.1.3 Market Segmentation
- 12.1.4 Regions Included
- 12.2 Introduction
- 12.3 Procedure Numbers
- 12.4 Market Overview
- 12.4.1 By Segment
- 12.4.2 By Region
- 12.5 Market Analysis And Forecast
- 12.5.1 System Placement
- 12.5.2 Robotic-Assisted Spine Surgery Capital Equipment Market
- 12.5.3 Robotic-Assisted Spine Surgery Disposables And Other Accessories Market
- 12.5.4 Robotic-Assisted Spine Surgery System Service And Maintenance Revenue Market
- 12.6 Drivers And Limiters
- 12.6.1 Market Drivers
- 12.6.2 Market Limiters
- 12.7 Competitive Market Share Analysis
- 12.7.1 Emerging Competitors
- Abbreviations
- Chart 12-1: Robotic-Assisted Spine Surgery System Market, Global, 2024 & 2031
- Chart 12-2: Robotic-Assisted Spine Surgery System Procedures, Global, 2024
- Chart 12-3: Robotic-Assisted Spine Surgery Procedures by Region, Global, 2021 – 2031
- Chart 12-4: Robotic-Assisted Spine Surgery System Market by Segment, Global, 2021 – 2031
- Chart 12-5: Robotic-Assisted Spine Surgery System Market by Region, Global, 2021 – 2031
- Chart 12-6: Leading Competitors, Robotic-Assisted Spine Surgery System Market, Global, 2024
- Figure 12-1: Robotic-Assisted Spine Surgery System Market Segmentation
- Figure 12-2: Robotic-Assisted Spine Surgery System Regions Covered, Global (1 of 2)
- Figure 12-3: Robotic-Assisted Spine Surgery System Regions Covered, Global (2 of 2)
- Figure 12-4: Robotic-Assisted Spine Surgery Procedures by Region, Global, 2021 – 2031
- Figure 12-5: Robotic-Assisted Spine Surgery Procedures by Country, North America, 2021 – 2031
- Figure 12-6: Robotic-Assisted Spine Surgery Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 12-7: Robotic-Assisted Spine Surgery Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 12-8: Robotic-Assisted Spine Surgery Procedures by Country, Western Europe, 2021 – 2031
- Figure 12-9: Robotic-Assisted Spine Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 12-10: Robotic-Assisted Spine Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 12-11: Robotic-Assisted Spine Surgery Procedures by Country, Middle East, 2021 – 2031
- Figure 12-12: Robotic-Assisted Spine Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 12-13: Robotic-Assisted Spine Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 12-14: Robotic-Assisted Spine Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 12-15: Robotic-Assisted Spine Surgery Procedures by Country, Africa, 2021 – 2031
- Figure 12-16: Robotic-Assisted Spine Surgery System Market by Segment, Global, 2021 – 2031 (US$M)
- Figure 12-17: Robotic-Assisted Spine Surgery System Market by Region, Global, 2021 – 2031 (US$M)
- Figure 12-18: System Placement, Robotic-Assisted Neurosurgery System Market, Global, 2021 – 2031
- Figure 12-19: Total Systems Placed, Robotic-Assisted Neurosurgery System Market, Global, 2021 – 2031
- Figure 12-20: System Leased or Placed under Financial Arrangement, Robotic-Assisted Neurosurgery System Market, Global, 2021 – 2031
- Figure 12-21: Robotic-Assisted Spine Surgery Capital Equipment Market, Global, 2021 – 2031
- Figure 12-22: Systems Sold under Outright Purchase by Region, Robotic-Assisted Spine Surgery Capital Equipment Market, Global, 2021 – 2031
- Figure 12-23: Installed Base by Region, Robotic-Assisted Spine Surgery Capital Equipment Market, Global, 2021 – 2031 (US$)
- Figure 12-24: Average Selling Price by Region, Robotic-Assisted Spine Surgery Capital Equipment Market, Global, 2021 – 2031 (US$)
- Figure 12-25: Market Value by Region, Robotic-Assisted Spine Surgery Capital Equipment Market, Global, 2021 – 2031 (US$M)
- Figure 12-26: Robotic-Assisted Spine Surgery Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 12-27: Units Sold by Region, Robotic-Assisted Spine Surgery Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 12-28: Average Selling Price by Region, Robotic-Assisted Spine Surgery Disposables and Other Accessories Market, Global, 2021 – 2031 (US$)
- Figure 12-29: Market Value by Region, Robotic-Assisted Spine Surgery Disposables and Other Accessories Market, Global, 2021 – 2031 (US$M)
- Figure 12-30: Robotic-Assisted Spine Surgery System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 12-31: Installed Base by Region, Robotic-Assisted Spine Surgery System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 12-32: Average Selling Price by Region, Robotic-Assisted Spine Surgery System Service and Maintenance Revenue Market, Global, 2021 – 2031 (US$)
- Figure 12-33: Market Value by Region, Robotic-Assisted Spine Surgery System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 12-34: Leading Competitors, Robotic-Assisted Spine Surgery System Market, Global, 2024
- Explore Report Options
- License Type
- Select the access level that fits your organization:
- Single License
- Individual use only.
- Site License
- Multiple users within one location.
- Corporate License
- Enterprise-wide access.
- Get a Quote
- Request Report Sample
- Related Reports
- Video, High-Tech and Integrated Operating Theater Equipment Market Overview | Europe | 2016-2022 | MedView
- Hybrid and Integrated Operating Room Technology Market Overview | Global | 2016-2022 | MedView
- MIS Sacroiliac Joint Fusion Market Analysis | United States | 2019-2025 | MedCore
- Capsule Endoscopy Market Size, Share & Trends Analysis | Global | 2025-2032 | MedCore | Includes: Camera Capsules, and Data Recorders
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

